The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

Clinical trial NCT03889626 · UNKNOWN

Trial details

NCT number: NCT03889626
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Stomach Neoplasms Gastrointestinal Neoplasms Stomach Diseases Digestive System Neoplasms Capecitabine Apatinib Neoplasms Molecular Mechanisms of Pharmacological Action

Start date: 2019-03-22
Primary completion: 2022-03-22
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.